Presentation is loading. Please wait.

Presentation is loading. Please wait.

Outcomes after Pancreatectomy with Routine Pasireotide Use

Similar presentations


Presentation on theme: "Outcomes after Pancreatectomy with Routine Pasireotide Use"— Presentation transcript:

1 Outcomes after Pancreatectomy with Routine Pasireotide Use
John W. Kunstman, MD, Debra A. Goldman, MS, Mithat Gönen, PhD, Vinod P. Balachandran, MD, FACS, Michael I. D'Angelica, MD, FACS, T Peter Kingham, MD, FACS, William R. Jarnagin, MD, FACS, Peter J. Allen, MD, FACS  Journal of the American College of Surgeons  Volume 228, Issue 2, Pages e2 (February 2019) DOI: /j.jamcollsurg Copyright © 2018 American College of Surgeons Terms and Conditions

2 Figure 1 Incidence of the primary end point (aggregate incidence of pancreatic fistula/leak/abscess) in the current study population routinely receiving pasireotide vs the control population that received placebo. Error bars indicate 95% CI. Journal of the American College of Surgeons  , e2DOI: ( /j.jamcollsurg ) Copyright © 2018 American College of Surgeons Terms and Conditions

3 eFigure 1 Schematic of study design noting enrollment and randomization from earlier controlled trial evaluating pasireotide in patients undergoing pancreatectomy17 compared with the current study, as indicated. Journal of the American College of Surgeons  , e2DOI: ( /j.jamcollsurg ) Copyright © 2018 American College of Surgeons Terms and Conditions


Download ppt "Outcomes after Pancreatectomy with Routine Pasireotide Use"

Similar presentations


Ads by Google